Survivor Debate: How Do We Best Assess Prostate Cancer Patients on Active Surveillance for Disease Progression?

Survivor Debate: How Do We Best Assess Prostate Cancer Patients on Active Surveillance for Disease Progression?

Friday, May 15, 2026 7:35 AM to 8:05 AM · 30 min. (America/New_York)

Hall D

Detail

Speakers

Department of Urology, The Royal Melbourne Hospital

Mark Emberton

University College London

Laurence Klotz

Professor of SurgerySunnybrook Health Sciences Centre

Wayne Brisbane

Assistant ProfessorUCLA Health

Plenary

Plenary: Friday Morning

Friday, May 15, 2026 7:30 AM to 11:45 AM

Adam Kibel · Mass General Brigham, Harvard University

David Penson · Vanderbilt University Medical Center

Registered attendees

Armando Juliao

Jefe Servicio UrologiaClinica Portoazul

Denis Seguier

Onco-Urology FellowLille University Hospital

Henri Morgan

UrologistHospital das Clínicas, Faculty of Medicine, University of São Paulo (HCFMUSP)

Log in

See all the content and easy-to-use features by logging in or registering!